157 related articles for article (PubMed ID: 20337631)
1. Testing a primary and a secondary endpoint in a group sequential design.
Tamhane AC; Mehta CR; Liu L
Biometrics; 2010 Dec; 66(4):1174-84. PubMed ID: 20337631
[TBL] [Abstract][Full Text] [Related]
2. A gatekeeping procedure to test a primary and a secondary endpoint in a group sequential design with multiple interim looks.
Tamhane AC; Gou J; Jennison C; Mehta CR; Curto T
Biometrics; 2018 Mar; 74(1):40-48. PubMed ID: 28589692
[TBL] [Abstract][Full Text] [Related]
3. Improved two-stage group sequential procedures for testing a secondary endpoint after the primary endpoint achieves significance.
Li H; Wang J; Luo X; Grechko J; Jennison C
Biom J; 2018 Sep; 60(5):893-902. PubMed ID: 29876964
[TBL] [Abstract][Full Text] [Related]
4. Adaptive extensions of a two-stage group sequential procedure for testing primary and secondary endpoints (I): unknown correlation between the endpoints.
Tamhane AC; Wu Y; Mehta CR
Stat Med; 2012 Aug; 31(19):2027-40. PubMed ID: 22729929
[TBL] [Abstract][Full Text] [Related]
5. Group sequential Holm and Hochberg procedures.
Tamhane AC; Xi D; Gou J
Stat Med; 2021 Oct; 40(24):5333-5350. PubMed ID: 34636081
[TBL] [Abstract][Full Text] [Related]
6. Allocating recycled significance levels in group sequential procedures for multiple endpoints.
Xi D; Tamhane AC
Biom J; 2015 Jan; 57(1):90-107. PubMed ID: 25355702
[TBL] [Abstract][Full Text] [Related]
7. On selecting the critical boundary functions in group-sequential trials with two time-to-event outcomes.
Hamasaki T; Hung HMJ; Hsiao CF; Evans SR
Contemp Clin Trials; 2021 Feb; 101():106244. PubMed ID: 33309946
[TBL] [Abstract][Full Text] [Related]
8. A decision rule for sequential monitoring of clinical trials with a primary and supportive outcome.
Zhao Y; Grambsch PM; Neaton JD
Clin Trials; 2007; 4(2):140-53. PubMed ID: 17456513
[TBL] [Abstract][Full Text] [Related]
9. Over-ruling a group sequential boundary--a stopping rule versus a guideline.
Lan KK; Lachin JM; Bautista O
Stat Med; 2003 Nov; 22(21):3347-55. PubMed ID: 14566919
[TBL] [Abstract][Full Text] [Related]
10. A note on familywise error rate for a primary and secondary endpoint.
Proschan MA; Follmann DA
Biometrics; 2023 Jun; 79(2):1114-1118. PubMed ID: 35355244
[TBL] [Abstract][Full Text] [Related]
11. Hierarchical testing of multiple endpoints in group-sequential trials.
Glimm E; Maurer W; Bretz F
Stat Med; 2010 Jan; 29(2):219-28. PubMed ID: 19827011
[TBL] [Abstract][Full Text] [Related]
12. An additive boundary for group sequential designs with connection to conditional error.
Xi D; Gallo P
Stat Med; 2019 Oct; 38(23):4656-4669. PubMed ID: 31338847
[TBL] [Abstract][Full Text] [Related]
13. CP function: an alpha spending function based on conditional power.
Jiang Z; Wang L; Li C; Xia J; Wang W
Stat Med; 2014 Nov; 33(26):4501-14. PubMed ID: 25100033
[TBL] [Abstract][Full Text] [Related]
14. Adjustment on the Type I Error Rate for a Clinical Trial Monitoring for both Intermediate and Primary Endpoints.
Halabi S
J Biom Biostat; 2012 May; 7():15. PubMed ID: 24466469
[TBL] [Abstract][Full Text] [Related]
15. Adaptive extensions of a two-stage group sequential procedure for testing primary and secondary endpoints (II): sample size re-estimation.
Tamhane AC; Wu Y; Mehta CR
Stat Med; 2012 Aug; 31(19):2041-54. PubMed ID: 22733687
[TBL] [Abstract][Full Text] [Related]
16. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
Lewis RJ; Lipsky AM; Berry DA
Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
[TBL] [Abstract][Full Text] [Related]
17. The performance of the O'Brien-Fleming multiple testing procedure in the presence of intraclass correlation.
Lui KJ
Biometrics; 1994 Mar; 50(1):232-6. PubMed ID: 8086606
[TBL] [Abstract][Full Text] [Related]
18. Alternatives to the standard Fleming, Harrington, and O'Brien futility boundary.
Anderson JR; High R
Clin Trials; 2011 Jun; 8(3):270-6. PubMed ID: 21441286
[TBL] [Abstract][Full Text] [Related]
19. Flexible designs by adaptive plans of generalized Pocock- and O'Brien-Fleming-type and by self-designing clinical trials.
Hartung J
Biom J; 2006 Aug; 48(4):521-36. PubMed ID: 16972703
[TBL] [Abstract][Full Text] [Related]
20. Symmetric group sequential test designs.
Emerson SS; Fleming TR
Biometrics; 1989 Sep; 45(3):905-23. PubMed ID: 2675998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
